New search | Conferencedetail
Print view
 
 

2nd Gene Therapy Immunogenicity

Evvnt Promotion / evvnt
-
03.08.2021 - 05.08.2021  Online
Time: 08:00 - 17:30
 
Conference themes
The 2nd Gene Therapy Immunogenicity Summit is the industry's definitive forum enabling you to better modulate, measure and predict immune response to your gene therapy candidate.

In the context of ever-increasing gene therapy clinical activity and uncertainty around immunogenicity challenges, the Gene Therapy Immunogenicity Summit will unite large pharma and innovative biotechs to ensure that you're up to speed on the latest approaches to predict, measure
Professional congress organizer (PCO)
Hanson Wade
Notes
Speakers: Andrew Byrnes, Head Gene Transfer and Immunogenicity Branch, FDA, Klaudia Kuranda, Immunology Lead, Spark Therapeutics, David Markusic, Research Professor, IUPUI, Cathryn Clary, Acting Chief Medical Officer, Bridge Bio and more.
 

Enquiries and Registration:

https://go.evvnt.com/754695-1?pid=4832
Ms. Ellie Saunders
 
Categories
General Medicine
Languages
English
Congress fees
Conference Only Ticket (First Release): $1599.0, Conference Only Ticket (Second Release): $1699.0, Conference Only Ticket (Third Release): $1899.0, Conference Only Ticket (Fourth Release): $1999.0, Conference Only Ticket (Final Price): $2099.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International promotes access to education and training for all regardless of social, geographic and national borders."

Helix - Forschung & Beratung WiennewTreeCenter of ExcellenceEuropean Health Forum GasteinAMREF - African Medical and Research FoundationSwiss Tropical and Public Health InstituteCharité International AcademyAGEM - Arbeitsgemeinschaft Ethnologie und Medizin